North America Ophthalmic Devices & Drugs Market - Growth, Trends, and Forecast (2022 - 2027)

The North America Ophthalmic Devices & Drugs Market is segmented By Product (Devices and Drugs), Disease, and Geography.

Market Snapshot

North America Ophthalmic Devices & Drugs
Study Period: 2017-2025
Base Year: 2021
CAGR: 5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The North America Ophthalmic Devices & Drugs Market is expected to grow with a CAGR of 5% during the forecasted period. Certain factors that are driving the growth of the market include demographic shift, the impact of the prevalence of eye disease, technological advancements in the field of ophthalmology, and rising geriatric population. The aging population is expected to burden all areas of healthcare, and ophthalmologists provide approximately 90% of their procedure-based services to seniors. There has been a rising prevalence of eye diseases, such as glaucoma, cataract, macular degeneration, and diabetic retinopathy in North American countries. For instance As per the statistics published by National Eye Institute, currently, around 1.3 million Americans are blind, and 2.9 million have low vision. An estimated 2.2 million Americans may face vision loss, and 5 million will have low vision by 2030. Hence, an increase in eye disorders will lead to the growing demand for drugs and devices.​

Moreover, In September 2019, Canon Xephilio OCT-A1 Optical Coherence Tomography device received the FDA 510(k) Clearance. This device features automated acquisition functionality, which makes it easy to use, allowing healthcare professionals to obtain high-quality reproducible scans and images.

Scope of the report

As per the scope of the report, ophthalmology devices are the equipment used for the diagnosis and treatment of various ophthalmic diseases, such as cataract, glaucoma, and refractive errors. Ophthalmic drugs are used to treat eye infections and some of the above-mentioned diseases. The drugs covered in the report are glaucoma drugs, retinal disorder drugs, dry eye disease drugs, drugs for infections, and other drugs

Report scope can be customized per your requirements. Click here.

Key Market Trends

Cataract Segment is Expected to Show Better Growth in the Forecast Years

Based on disease, the market is segmented into glaucoma, cataract, age-related macular degeneration, inflammatory diseases, refractive disorders, and other diseases. As per the American Academy of Ophthalmology, it is estimated that by 2050, around 50 million people in the United States are expected to suffer from cataracts, which is one of the leading causes of blindness in the United States. Cataract surgery remains the most effective way to help restore vision for people with cataracts. Hence, with the rising burden of eye disease in North America, the market is expected to grow in the forecast period.

key trend NAopthalmic.png

Competitive Landscape

The North America Ophthalmic Devices & Drugs Market is fragmented competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Alcon Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, Essilor International SA, Haag-Streit Group, Johnson & Johnson, Nidek Co. Ltd, Topcon Corporation, Ziemer Group AG

Table of Contents


    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Demographic Shift and Impact of Prevalence of Eye Disease

      2. 4.2.2 Technological Advancements in the Field of Ophthalmology

    3. 4.3 Market Restraints

      1. 4.3.1 Higher Cost of the Ophthalmic Devices and Treatment

      2. 4.3.2 Strict FDA Guidelines for Drug Approval

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 Devices

        1. Surgical Devices

          1. Intraocular Lenses

          2. Ophthalmic Lasers

          3. Other Surgical Devices

        2. Diagnostic Devices

      2. 5.1.2 Drugs

        1. Glaucoma Drugs

        2. Retinal Disorder Drugs

        3. Dry Eye Drugs

        4. Allergic Conjunctivitis and Inflammation Drugs

        5. Other Drugs

    2. 5.2 By Disease

      1. 5.2.1 Glaucoma

      2. 5.2.2 Cataract

      3. 5.2.3 Age-Related Macular Degeneration

      4. 5.2.4 Inflammatory Diseases

      5. 5.2.5 Refractive Disorders

      6. 5.2.6 Other Diseases

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico


    1. 6.1 Company Profiles

      1. 6.1.1 Alcon Inc.

      2. 6.1.2 Bausch Health Companies Inc.

      3. 6.1.3 Carl Zeiss Meditec AG

      4. 6.1.4 Essilor International SA

      5. 6.1.5 Haag-Streit Group

      6. 6.1.6 Johnson & Johnson

      7. 6.1.7 Nidek Co. Ltd

      8. 6.1.8 Topcon Corporation

      9. 6.1.9 Ziemer Group AG

    2. *List Not Exhaustive

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The North America Ophthalmic Devices & Drugs Market market is studied from 2017 - 2025.

The North America Ophthalmic Devices & Drugs Market is growing at a CAGR of 5% over the next 5 years.

Alcon Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, Haag-Streit Group, Johnson & Johnson are the major companies operating in North America Ophthalmic Devices & Drugs Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!